Orchestra BioMed (OBIO) Director Chris Cleary Withholds 4,238 Shares

What Happened

• Director Chris Cleary had 4,238 shares withheld by Orchestra BioMed to satisfy tax withholding related to the vesting of restricted stock units (RSUs). The withholding was reported at $4.42 per share, for a notional value of $18,732. This was a tax-withholding disposition of shares, not an open-market sale.

Key Details

• Transaction date: 2026-08-12; Filing date: 2026-08-14 (Form 4 accession 0001104659-26-097174).
• Shares withheld/disposed: 4,238 at $4.42 per share (total ~$18,732).
• Shares owned after transaction: Not specified in the provided report.
• Footnote: The issuer withheld shares to satisfy tax obligations on RSU vesting; no shares were sold in the market to cover the tax bill.
• Transaction type/code: Tax withholding on award vesting (code F).

Context

• This is a routine tax-withholding event when RSUs vest and does not reflect an open-market sale or an additional purchase; such withholdings are common and typically neutral with respect to insider sentiment.